Latest Articles

Publication Date
Covid-19: Person tests positive at Middlemore Hospital, 40 patients considered contacts - RNZ

Covid-19: Person tests positive at Middlemore Hospital, 40 patients considered contacts RNZ

Published: June 19, 2026, 7:29 a.m.
Several Covid-19 cases among patients at Porirua's Kenepuru Hospital - RNZ

Several Covid-19 cases among patients at Porirua's Kenepuru Hospital RNZ

Published: June 19, 2026, 5:08 a.m.
NEWS: Hypermobility Patients Waiting Up to 21 Years for Diagnosis - Practice Business

NEWS: Hypermobility Patients Waiting Up to 21 Years for Diagnosis Practice Business

Published: June 18, 2026, 10:23 a.m.
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial - Vietnam Investment Review - VIR

Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial Vietnam Investment Review - VIR

Published: June 18, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Macau Business

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Macau Business

Published: June 18, 2026, 7:26 a.m.
Awareness gap linked to years-long diagnostic delays for endometriosis patients - b2bnews.co.nz

Awareness gap linked to years-long diagnostic delays for endometriosis patients b2bnews.co.nz

Published: June 18, 2026, 5:16 a.m.
How femtech is helping fibromyalgia patients - FemTech World

How femtech is helping fibromyalgia patients FemTech World

Published: June 17, 2026, 11:26 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted

Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times

Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore

Published: June 17, 2026, 8:05 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!